Home › NDC Lookup › RxCUI directory › RxCUI 1299143

Dexbrompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution — RxCUI 1299143

Name: Dexbrompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Sol… (RxCUI 1299143)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1299143 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1299143

Official nameDexbrompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asdexbrompheniramine maleate 1 MG / pseudoephedrine hydrochloride 30 MG per 5 ML Oral Solution; dexbrompheniramine maleate 1 MG / pseudoephedrine HCl 30 MG in 5 mL Oral Solution

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Pseudoephedrine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

It temporarily relieves nasal congestion from the common cold, hay fever or other upper respiratory allergies. Many products also relieve sinus congestion and pressure.
It depends on the product. Regular tablets and softgels are usually taken every 4 to 6 hours, while 12-hour extended-release tablets are taken every 12 hours. Check your box for th...
No. Swallow them whole. Don't divide, crush, chew or dissolve them. Seeing part of the tablet in your stool can happen and is normal.
Can I crush or chew the extended-release tablets?

📖 Read our full Pseudoephedrine guide →

🕸️ Concept Web — How Dexbrompheniramine maleate 0.2 MG/ML / pseudoeph... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Dexbrompheniramine maleate 0.2 MG/ML / pseudoephedrine hydrochloride 6 MG/ML Oral Solution RxCUI 1299143 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Dexbrompheniramine 22696 IN
- Pseudoephedrine 8896 IN
- Dexbrompheniramine / pseudoephedrine 400674 MIN
- Dexbrompheniramine maleate 48936 PIN
- Pseudoephedrine hydrochloride 91168 PIN
Dose forms 9

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Dexbrompheniramine / pseudoephedrine Oral Solution 757267 SCDF
- Dexbrompheniramine maleate / pseudoephedrine hydrochloride Oral Solution 2645591 SCDFP
- Dexbrompheniramine / pseudoephedrine Oral Liquid Product 1157224 SCDG
- Dexbrompheniramine / pseudoephedrine Oral Product 1157225 SCDG
- Dexbrompheniramine maleate / pseudoephedrine hydrochloride Oral Liquid Product 2662446 SCDGP
- Dexbrompheniramine maleate / pseudoephedrine hydrochloride Oral Product 2662083 SCDGP
- Oral Solution 316968 DF
- Oral Liquid Product 1151137 DFG
- +1 more in this family
Clinical & branded drugs 2

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Dexbrompheniramine maleate 0.2 MG/ML 1299142 SCDC
- Pseudoephedrine hydrochloride 6 MG/ML 995982 SCDC

Showing up to 8 concepts per family — 15 of 16 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Dexbrompheniramine maleate 0.2 MG/ML SCDC · 1299142
Pseudoephedrine hydrochloride 6 MG/ML SCDC · 995982
Dexbrompheniramine / pseudoephedrine Oral Solution SCDF · 757267
Dexbrompheniramine maleate / pseudoephedrine hydrochloride Oral Solution SCDFP · 2645591
Dexbrompheniramine / pseudoephedrine Oral Liquid Product SCDG · 1157224
Dexbrompheniramine / pseudoephedrine Oral Product SCDG · 1157225
Dexbrompheniramine maleate / pseudoephedrine hydrochloride Oral Liquid Product SCDGP · 2662446
Dexbrompheniramine maleate / pseudoephedrine hydrochloride Oral Product SCDGP · 2662083

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1299143 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
54859-0803-16	473 mL in 1 BOTTLE (54859-803-16)	Conex Pediatric	Llorens Pharmaceutical International Division	2024-12-01
63102-0109-16	473 mL in 1 BOTTLE (63102-109-16)	ACTICON PEDIATRIC	ACTIPHARMA, LLC	2025-07-17

Observed labelers: ACTIPHARMA, LLC (1) · Llorens Pharmaceutical International Division (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.